Home
Contact Us
Aggregated China Business Blogs
2021-02-06
Jingxin Pharmaceutical's 500 million yuan fixed increase is approved to issue fair value to help increase net profit over 100 million yuan-Finance-
Aggregated Source:
Caishen.Co
Caishen.Co delivers
Primary Data for China`s Secondary Investment and Stock Markets
. Full details at
Caishen.Co
.
Original URL:
Click here to visit original article
Copyright
Caishen.Co
Related Posts
Sequoia Capital Leads $10M Series B In China’s 1006.tv
BMW’s China joint venture hits speed bump
Biotech BAT1706 (bevacizumab) injection authorizes Biomm to sell Biotech in the Brazilian market_Sina Finance_Sina.com
Asian shares set for 3rd losing week on China woes, US rates
China, Russia and the ‘Sinatra doctrine’
Ping An Real Estate Commits $300M To e-Shang Redwood’s Japan Projects
Education Without Borders
Inequality Is An Unavoidable By-product Of China’s Growth Model
China frees teenager in online rumour case
China Media Capital Invests In Caixin Media
SEARCH
Browse News
February 2021
S
M
T
W
T
F
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
« Jan
Mar »
Useful Sites
China Media Blog
China Legal Blog
China Travel Blog
Caishen.Co
ChinaPulse.com
ZhongjintouX.com